Mindaros, Romeo P.

HRN: 24-38-15  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
08/14/2024
08/21/2024
IV
500mg
OD
Septic Shock Sec To HAP
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaUnspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: